Xcout Intel
Octave Bioscience Inc
Octave Bioscience, Inc. is a healthcare and life sciences company focused on precision neurology for multiple sclerosis (MS) care. It provides advanced measurement tools and clinical solutions to improve patient management.
Subscribe to see Octave Bioscience Inc’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Octave Bioscience Inc at a glance
Octave Bioscience Inc is a healthcare company headquartered in United States. Its most recent funding round, Series C, raised $35M in September 2025. Xcout tracks 19 named people at Octave Bioscience Inc, including Doug Biehn (Chief Executive Officer).
Octave Bioscience Inc leadership
- Doug BiehnChief Executive Officer
- Marcel KonradChief Financial Officer
- Debbie LedetChief Access Officer
- Kirk StockwoodSenior Vice President, Commercial
- David BrazelVice President, Data Science
- Jennifer MellumVice President, Marketing
13 more named people on record for Octave Bioscience Inc, with roles, board committees and tenure — see the full roster →
Octave Bioscience Inc funding rounds
The 6 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series C | $35M | 10 named | |
| SEC Form D filing | $31.8M | — | |
| SEC Form D filing | $7M | — | |
| Series C | $30M | 10 named | |
| SEC Form D filing | $32.5M | — | |
| SEC Form D filing | $32M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Octave Bioscience Inc competitors
A few of Octave Bioscience Inc's closest competitors — see the full list of competitors and alternatives →
NeuroVision Imaging, Inc. is a healthcare technology company headquartered in Sacramento, California. Founded in 2010, the company develops digital imaging and diagnostic solutions to identify retinal biomarkers and neurological conditions.
Moleculera BioSciences is a precision medicine company dedicated to transforming patient care. The company develops next-generation diagnostic and predictive treatment algorithms for neurological and psychiatric conditions.
Durin Life Sciences develops Duritect™, a blood-based test that combines autoantibody biomarkers with machine learning technology to assess patients' risk of having Alzheimer's disease or Parkinson's disease. The company provides laboratory analysis services to process these blood samples and deliver risk score reports to physicians and patients.
Orchestra Health Technologies provides a platform combining proprietary software and care navigators to streamline the oncology diagnostic journey from biopsy to treatment decisions. The company serves cancer patients, oncologists, pathologists, and healthcare executives by coordinating pathology, molecular testing, and multi-disciplinary team workflows to accelerate precision medicine.
C. Light Technologies is a U.S. healthcare technology company developing noninvasive, high-precision eye-tracking systems that measure eye movements as biomarkers of neurological health. Its technology is intended for clinicians and researchers studying or assessing conditions such as multiple sclerosis and other neurologic disorders.
Get Octave Bioscience Inc's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Octave Bioscience Inc in Xcout Intel
- 19 named people with titles, LinkedIn and board committees
- 7 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access